Our focus on transitions of care will be supporting patients in that critical, and high-risk, time between a hospital or rehab discharge and getting in to see their PCP or specialist for a follow-up visit.
Our focus on end-of-life care will be to increase the number of patients dying from cancer who receive at least 10 days of hospice care – an accepted metric of high quality end-of-life care. Because many patients wish to have care focused on their comfort at end-of-life, involvement of specialty palliative care early in the disease course will also be a focus. Palliative care has been shown to increase duration of hospice care, notably without changing how long a patient lives.
Supporting ACO Participants
The ACO’s governing board, leaders and team members are excited to partner with participants to make real improvements in care variation reduction. The ACO has developed powerful resources to help ensure progress in these areas, including the newly-released Value Report analytics tool and the solution-oriented conversations it makes possible.
There is no doubt we’ve entered a time of sudden and radical change in health care. With the close collaboration of the ACO and participating practices, that change can be transformed into an opportunity – an opportunity to improve patient outcomes and lower total cost of care. I look forward to what we can achieve together in the consequential years to come.
Carl DeMars, MD
VP. Physician and APP Services, Coastal Region, MaineHealth
MHACO Board Chair
¹Atsma F, Elwyn G, Westert G. Understanding unwarranted variation in clinical practice: a focus on network effects, reflective medicine and learning health systems. Int J Qual Health Care. 2020 Jun 4;32(4):271-274. doi: 10.1093/intqhc/mzaa023. PMID: 32319525; PMCID: PMC7270826.